NCT02408159View on ClinicalTrials.gov

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

PHASE4TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

March 31, 2017

Conditions
Psoriasis
Interventions
DRUG

Varicella Zoster Vaccine

DRUG

Placebo

Trial Locations (3)

Unknown

Inno-6041 study site, London

Inno-6041 study site, Markham

H2K 4L5

Innovaderm Research Inc., Montreal

Sponsors
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Innovaderm Research Inc.

OTHER